Blooming Future Launches Operations as Part of Braskem’s Expanding Sustainable Fleet

Blooming Future Begins Operations, Expanding Braskem’s Sustainable Fleet Initiative

Blooming Future Launches Operations as Part of Braskem’s Expanding Sustainable Fleet Braskem the largest polyolefins producer in the Americas and global leader in the production of biopolymers on an industrial scale announces that Braskem Trading & Shipping (BT&S) has launched the…

Read MoreBlooming Future Begins Operations, Expanding Braskem’s Sustainable Fleet Initiative
Laprophan

Laprophan Finalizes Rivopharm Acquisition, Strengthening Global Growth and International Market Expansion

Laprophan Completes the Acquisition of Rivopharm, Accelerating Its International Expansion Strategy Laprophan Group, the pioneer and one of Morocco’s leading pharmaceutical groups, announced the successful completion of the acquisition of a controlling stake in Rivopharm, a Switzerland-based pharmaceutical company specialized in…

Read MoreLaprophan Finalizes Rivopharm Acquisition, Strengthening Global Growth and International Market Expansion
Real Chemistry

Real Chemistry Unifies Omnichannel Services Under Real Chemistry Media

Real Chemistry Unifies Omnichannel Offering as Real Chemistry Media, a Technology-led, Healthcare-focused Practice of the Future Real Chemistry, a leader in AI-driven insights and marketing and communications exclusively for the healthcare and life sciences sectors, announced the full integration of…

Read MoreReal Chemistry Unifies Omnichannel Services Under Real Chemistry Media
CareDx Presents

CareDx Presents Extensive Precision Medicine Research at the 2026 American Transplant Congress

CareDx Precision Medicine Diagnostics Showcased in Over 30 Abstracts and 9 Oral Presentations at the 2026 American Transplant Congress CareDx, Inc. The Transplant Company™, a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high‑value…

Read MoreCareDx Presents Extensive Precision Medicine Research at the 2026 American Transplant Congress
Nomic

Nomic and Wellcome Sanger Institute Partner to Advance Protein-Level Insights into Immune Diversity Genetics

Nomic and Wellcome Sanger Institute Collaborate to Bring Protein-Level Resolution to the Genetics of Immune Diversity Nomic Bio Inc. announced a research collaboration with the Wellcome Sanger Institute to perform large-scale proteomic profiling of human-derived peripheral blood mononuclear cell (PBMC)…

Read MoreNomic and Wellcome Sanger Institute Partner to Advance Protein-Level Insights into Immune Diversity Genetics
Osmo

Osmo to Auction 10 Proprietary AI-Created Fragrance Ingredients

Osmo To Sell 10 Proprietary AI-Developed Fragrance Ingredients In First-of-its-Kind Auction Osmo, the olfactory technology company, announced the first-ever auction of fragrance captives, offering exclusive, perpetual licenses to 10 proprietary molecules developed through its Olfactory Intelligence platform. Launching at the…

Read MoreOsmo to Auction 10 Proprietary AI-Created Fragrance Ingredients
Gurobi

Gurobi Research Team Earns Recognition from Top Scientific Organizations

Gurobi’s Research Leadership Recognized Across Leading Scientific Organizations Gurobi Optimization, LLC, the leader in decision intelligence technology, announced recognitions received by Dr. Edward Rothberg and Dr. Andreas Wächter from leading academic and industry organizations for research that has had lasting…

Read MoreGurobi Research Team Earns Recognition from Top Scientific Organizations
Pelago Bioscience

Pelago Bioscience Acquires RG Discovery to Create Integrated Drug Discovery Platform

Pelago Bioscience acquires RG Discovery, forming an integrated drug discovery partner covering biology and chemistry Pelago Bioscience, a contract research organization (CRO) specializing in drug discovery and renowned for its cutting-edge cell target engagement assays, is pleased to announce the…

Read MorePelago Bioscience Acquires RG Discovery to Create Integrated Drug Discovery Platform
cTAP

cTAP Unveils New Prognostic Score to Better Predict Loss of Ambulation in Duchenne Muscular Dystrophy

cTAP Announces Novel Prognostic Score Developed for Duchenne Muscular Dystrophy Patients Offers Improved Prediction of Loss of Ambulation The Collaborative Trajectory Analysis Project (cTAP) announces the publication of a novel, validated prognostic score for predicting the loss of ambulation (LoA)…

Read MorecTAP Unveils New Prognostic Score to Better Predict Loss of Ambulation in Duchenne Muscular Dystrophy
Takeda

Takeda’s Oveporexton Improves Daily Function, Cognition, and Sleep in Narcolepsy Type 1

New Pivotal Study Data Show Takeda’s Oveporexton Improved Daily Function, Cognition and Nighttime Sleep for People with Narcolepsy Type 1 Takeda presented additional results from two pivotal studies at SLEEP 2026, showing oveporexton (TAK-861), an oral orexin receptor 2 (OX2R)-selective…

Read MoreTakeda’s Oveporexton Improves Daily Function, Cognition, and Sleep in Narcolepsy Type 1